Hospice valuation: what a home health or hospice business is worth in 2026
Owner-operated home health and hospice agencies sell for a median 3.3x-3.4x SDE (seller's discretionary earnings) across size bands in Axia Growth's Healthcare sector data, a sector proxy updated October 28, 2026.
Multiples by size, with the source and date of each figure
In Axia Growth's analysis of closed small-business sales, home health and hospice agencies are grouped in the Healthcare sector, where businesses with under $500K of SDE sold for a median 3.4x SDE (middle half 2.7x-4.2x) across 182 sales, updated October 28, 2026. According to Mertz Taggart, Kinderhook Industries took Enhabit private at a 10.2x EBITDA multiple, roughly $1.1 billion enterprise value on $108 million of EBITDA. The two figures use different bases: Axia Growth's figure is a multiple of SDE from owner-operated small-business sales, while the Mertz Taggart figure is a multiple of EBITDA from larger, often private-equity-backed deals, so the higher number is expected, not a contradiction.
Home-based care M&A slowed by count but not by dollars in 2026: Mertz Taggart tracked 16 closed transactions in Q2 2026, down from 27 in Q1, while Kinderhook took Enhabit private at roughly $1.1 billion. Reimbursement is mixed, with a 2.3% FY 2027 hospice payment update against a 1.3% aggregate home health cut for CY 2026. A nationwide CMS enrollment moratorium that began May 13, 2026 now shapes how deals are structured.
Why published multiples differ
Published multiples differ mostly because they use different earnings and deal sizes. Small, owner-run businesses (under $2M of earnings) are priced on SDE, seller's discretionary earnings, which adds back the owner's pay, so SDE multiples are lower. From $2M of earnings up, buyers price on EBITDA, and multiples rise with size. Averages that mix sizes, or quote larger private-equity deals, read higher than a small-business sale.
Multiples by deal size
Sector: Healthcare. Median and middle half (p25-p75) of sale price to earnings.
Closed small-business sales in the Healthcare sector, by deal size. Axia Growth analysis of closed small-business sales, updated October 28, 2026.
Size band
n
Median multiple
p25-p75
Basis
Under $500K SDE
182
3.4x
2.7x-4.2x
SDE
$500K-$1M SDE
42
3.4x
2.5x-4.4x
SDE
$1M-$2M SDE
22
3.3x
2.7x-7.5x
SDE
$2M-$3M EBITDA
13
5.1x
3.1x-10.9x
EBITDA
$5M-$10M EBITDA
14
8.8x
3.4x-10.7x
EBITDA
$10M+ EBITDA
17
12.9x
9.4x-18.5x
EBITDA
Source: Axia Growth analysis of 4,554 closed small-business sales over $500K, aggregated and de-identified. Data as of 2026-10-28. Methodology.
No published cell for the Healthcare size band: $3M-$5M EBITDA. Each has fewer than 10 closed sales, so Axia Growth does not estimate a multiple for it.
How much is a hospice or home health agency worth?
Hospice and home health agencies sell for a multiple of earnings. In Axia Growth's Healthcare sector data, businesses with under $500K of SDE sold for a median 3.4x SDE, with the middle half between 2.7x and 4.2x, across 182 closed sales. With $500K-$1M of SDE, the median was 3.4x SDE (42 sales).
Source: Axia Growth analysis of 4,554 closed small-business sales over $500K, aggregated and de-identified. Data as of October 28, 2026.
Geography matters for hospice in particular. CMS has imposed heightened screening on hospices newly enrolling or changing ownership in Arizona, California, Georgia, Nevada, Ohio, and Texas. Targets in those states face longer diligence and more structuring questions.
Hospice buyers also model cap exposure. Medicare applies a statutory aggregate cap to the payments each hospice receives annually, and the FY 2027 cap is $36,174.75. A hospice with long average lengths of stay can owe repayments, so buyers review cap liability by year.
What raises the multiple
A home health or hospice agency that reaches the top of the buyer range typically shows:
A Medicare enrollment history outside the 36-month window, with no pending change-of-ownership issues.
Stable or rising census fed by several referral sources, not a single hospital or physician group.
Clean state surveys and accreditation, and no open program-integrity reviews.
For hospice, a documented history of staying under the aggregate cap, with no recent repayment demands.
State review adds another layer. At least 14 states now require advance notice to the attorney general or a related agency before a private equity, hedge fund, or MSO-affiliated transaction closes. Earnouts and seller rollover are common in sponsor-backed healthcare deals generally, but none of the sources above break out their use for this segment.
Outlook
Expect transaction structure to drive the next 12 to 24 months. The moratorium is initially set to run through approximately November 13, 2026, subject to six-month extensions. While it lasts, agencies with long, clean enrollment histories hold scarce Medicare numbers that new entrants cannot replicate.
Hospice should keep drawing sponsor capital because of steady rate updates, while home health depends on whether CMS holds to the proposed CY 2027 increase. Fraud enforcement and state transaction-review laws will keep diligence long. Owners who clean up compliance and enrollment records before a process are best placed to hold value through closing.
What multiple do home health and hospice agencies sell for?
Owner-operated home health and hospice agencies sell for a median 3.3x-3.4x SDE (seller's discretionary earnings) across size bands in Axia Growth's Healthcare sector data, a sector proxy updated October 28, 2026. The SDE rows are a sector proxy: Axia Growth publishes multiples for the Healthcare sector, not for home health and hospice agencies alone. Source: Axia Growth analysis of 4,554 closed small-business sales over $500K, aggregated and de-identified. Axia Growth groups home health and hospice agencies in the Healthcare sector, the closest published proxy: businesses with under $500K of SDE sold for a median 3.4x SDE across 182 sales (Axia Growth analysis of closed small-business sales, updated October 28, 2026).
What is a home health or hospice agency worth?
In Axia Growth's analysis of closed small-business sales, home health and hospice agencies are grouped in the Healthcare sector, where businesses with under $500K of SDE sold for a median 3.4x SDE (middle half 2.7x-4.2x) across 182 sales, updated October 28, 2026. According to Mertz Taggart, Kinderhook Industries took Enhabit private at a 10.2x EBITDA multiple, roughly $1.1 billion enterprise value on $108 million of EBITDA. The two figures use different bases: Axia Growth's figure is a multiple of SDE from owner-operated small-business sales, while the Mertz Taggart figure is a multiple of EBITDA from larger, often private-equity-backed deals, so the higher number is expected, not a contradiction.
SDE or EBITDA: which applies to my home health or hospice agency?
Axia Growth reports multiples of SDE (seller's discretionary earnings) for businesses with under $2M of earnings, where owner-operated businesses are usually priced, and multiples of EBITDA from $2M up, matching how buyers and brokers talk about deal size. For the Healthcare sector, Axia Growth publishes both SDE and EBITDA bands.
How does the 2026 CMS enrollment moratorium affect a sale?
CMS imposed a six-month nationwide moratorium on new home health and hospice Medicare enrollments on May 13, 2026, initially running to about November 13, 2026. Any deal that requires a new enrollment is effectively blocked, so buyers favor equity structures that keep the existing Medicare number. Source: Nixon Peabody.
What is the hospice 36-month rule?
An agency that was acquired, changed ownership, or was initially enrolled within the prior 36 months may face restrictions on a subsequent change of ownership. In some cases the buyer must re-enroll the agency entirely, which the current moratorium does not allow. Source: Mertz Taggart.
How do I get a value range for my business?
Enter your industry and annual earnings in the free business value calculator for a value range drawn from the same closed-sales data. The multiples by sector page shows every published size band.
In Axia Growth's analysis of closed small-business sales, home health and hospice agencies are grouped in the Healthcare sector, where businesses with under $500K of SDE sold for a median 3.4x SDE (middle half 2.7x-4.2x) across 182 sales, updated October 28, 2026. According to Mertz Taggart, Kinderhook Industries took Enhabit private at a 10.2x EBITDA multiple, roughly $1.1 billion enterprise value on $108 million of EBITDA. The two figures use different bases: Axia Growth's figure is a multiple of SDE from owner-operated small-business sales, while the Mertz Taggart figure is a multiple of EBITDA from larger, often private-equity-backed deals, so the higher number is expected, not a contradiction. Home health and hospice M&A in 2026: 16 closed deals in Q2, a 2.3% FY 2027 hospice rate update, and a CMS enrollment moratorium reshaping deal structure.
When using information from this guide, cite Axia Growth and link to this page.
Axia Growth. Home Health & Hospice M&A. Updated 2026-11-05. https://axiagrowth.com/resources/industries/healthcare/home-health-hospice
For buyers
Have a mandate in Home Health & Hospice? Share your buy box.
Axia Growth LLC provides deal origination services and is not a registered broker-dealer, investment adviser, bank, or depository institution. Where Axia's compensation is contingent on closing, it relies on the M&A broker exemption (15 U.S.C. § 78o(b)(13)) and analogous state exemptions, where available. Axia is typically engaged and paid by the acquirer, does not represent sellers, and does not provide, arrange, or receive compensation for transaction financing. See full disclaimer: /legal/disclaimer